FH Europe News

Frazer Goodwin joins FH Europe as Senior Policy Projects Manager on February 1st, 2022. In this newly created role, Frazer’s focus for the forthcoming period will be on the EU policy dimension to promote FH paediatric screening across the EU. As such he will be...

“Homozygous familial hypercholesterolemia is a rare condition, extraordinarily difficult to treat, and without early identification and experienced care, leads to cardiac consequences early in life and often, death by age 30 years. New medications are on the horizon,...

In the January edition of FH Europe’s Heart Beat newsletter you’ll find the following: Information on our dedicated Policy Advisory Committee tasked with advocating for implementation of FH child screening across Europe. Insights on how we are working with people...

We are growing and need a superhero to help us deliver on our mission. The Virtual Office Manager and Executive Assistant plays a pivotal role in the day to day running of FH Europe’s team and wider voluntary structures of the charity.

Find the outcomes of the latest research on major adverse events caused by a rare and severe form of familial hypercholesterolaemia summarised for our community. A lay summary of “Major adverse cardiovascular events in homozygous familial hypercholesterolaemia: a...